3) Grander D, et al:Influence of interferon on antibody production and viability of malignant cells from patients with multiple myeloma. Eur. J. Haematol. 46:17, 1991.
4) McKusick VA:Mendelian inheritance in man. Catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes, sixth ed. The Johns Hopkins University Press, Baltimore, 1983.
5) Weil D, Bernard M, Combates N, et al:Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant. J. Biol. Chem. 263:8561-8564, 1988.
6) Cole WG, Chiodo AA, Lamande SR, et al:A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV. J. Biol. Chem. 265:17070-17077, 1990.
8) Vissing H, D'Alessio M, Lee B, et al:Glycine to serine substitution in the triple helical domain of proα1 (II) collagen results in a lethal perinatal form of short-limbed dwarfism. J. Biol. Chem. 264:18265-18267, 1989.
9) Ahmad NN, Ala-Kokko L, Knowlton RG, et al:A stop codon in the gene for type II procollagen (COL2A1) causes one variant of arthro-ophthalmopathy (the Stickler syndrome). Am. J. Hum. Genet. 47:A206, 1990.
10) Ala-Kokko L, Baldwin CT, Moskowitz RW, et al:Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc. Natl. Acad. Sci. USA 87:6565-6568, 1990.
11) Bernard M, Yoshioka H, Rodriguez E, et al:Cloning and sequencing of pro-α1 (XI) collagen cDNA demonstrates that type XI belongs to the fibrillar class of collagens and reveals that the expression of the gene is not restricted to cartilagenous tissue. J. Biol. Chem. 263:17159-17166, 1988.
12) Kimura T, Mattei M-G, Stevens JW, et al:Molecular cloning of rat and human type IX collagen cDNA and localization of the α1 (IX) gene on the human chromosome 6. Eur. J. Biochem. 179:71-78, 1989.
13) Kimura T, Cheah KSE, Chan SDH, et al:The human α2 (XI) collagen (COL11A2) chain. J. Biol. Chem. 264:13910-13916, 1989.
14) Spotila L, Constantinou CD, Sereda L, et al:Substitution of serine for gly α2-661 in the gene for type I procollagen (COL1A2) as a cause of post-menopausal osteoporosis. Am. J. Hum. Genet. 47:A237, 1990.
16) Nakata K, Ono K, Miyazaki J, et al:Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing α1 (IX) collagen chains with a central deletion. Proc. Natl. Acad. Sci. USA 90:2870-2874, 1993.
7) Kagawa H, Okubo S and Yasunaga K:Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and analysis of the multimeric structure of von Willebrand factor (vWF). Int. J. Hematol. 54:429-439, 1991.
1) Horiuchi A, et al:Function of thymic reticuloepithelial cells in New Zealand mice. Acta Med. Kinki Univ. 4:345, 1979.
2) Minoda M and Horiuchi A:Function of thymic reticuloepithelial cells in mice. Thymic reticuloepithelial cells and T cell differentiation. Acta Haematol. Jap. 48:992, 1985.
3) Minoda M and Horiuchi A:The function of thymic reticuloepithelial cells in New Zealand mice. Thymus 5:363, 1983
4) Minoda M and Horiuchi A:The effects of macrophages on interleukin 2 production in thymocytes of New Zealand black mice. J. Clin. Lab. Immunol. 22:29, 1987.
5) Minoda M, Senda S and Horiuchi A:The relationship between the defect in the syngeneic mixed lymphocyte reaction and thymic abnormality in New Zealand mice. J. Clin. Lab. Immunol. 23:101, 1987.
6) Minoda M, Funauchi M and Horiuchi A:Effect of interferon-γ on the abnormality of T cell activation in NZB mice. Clin. Immunol. Immunopathol. 49:283, 1988.
7) Minoda M, et al:Examination of the inhibitory effects of interferon-γ on interleukin-4-induced stimulation of resting B cells from NZB/NZW F1 mice. Clin. Exp. Immunol. 78:115, 1989.